SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-23-000034
Filing Date
2023-05-09
Accepted
2023-05-09 16:16:45
Documents
90
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20230331.htm   iXBRL 10-Q 1347449
2 EX-31.1 supn-20230331x10qxex311.htm EX-31.1 9754
3 EX-31.2 supn-20230331x10qxex312.htm EX-31.2 10115
4 EX-32.1 supn-20230331x10qxex321.htm EX-32.1 4996
5 EX-32.2 supn-20230331x10qxex322.htm EX-32.2 5017
  Complete submission text file 0001356576-23-000034.txt   7317268

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20230331.xsd EX-101.SCH 49582
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20230331_cal.xml EX-101.CAL 88381
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20230331_def.xml EX-101.DEF 257959
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20230331_lab.xml EX-101.LAB 634383
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20230331_pre.xml EX-101.PRE 428945
84 EXTRACTED XBRL INSTANCE DOCUMENT supn-20230331_htm.xml XML 1216729
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 23902270
SIC: 2834 Pharmaceutical Preparations